Conditioned Placebo Effects and Treatment of Hypertension
2 other identifiers
interventional
N/A
0 countries
N/A
Brief Summary
To compare the unconditioned and conditioned effects of placebo capsules in the treatment of patients with borderline hypertension (BH).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2002
Typical duration for phase_2 cardiovascular-diseases
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2002
CompletedFirst Submitted
Initial submission to the registry
December 21, 2005
CompletedFirst Posted
Study publicly available on registry
December 23, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedFebruary 18, 2016
January 1, 2008
4.8 years
December 21, 2005
February 17, 2016
Conditions
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
Thomas Pickering
Columbia University Health Sciences
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
December 21, 2005
First Posted
December 23, 2005
Study Start
September 1, 2002
Primary Completion
July 1, 2007
Study Completion
July 1, 2007
Last Updated
February 18, 2016
Record last verified: 2008-01